USD 0.74
(1.89%)
Breakdown | 2023 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 548 Thousand | -330.27 Thousand | -2.01 Million | 171.01 Thousand | 444.76 Thousand | 187.45 Thousand |
Net Income | -8.53 Million | -4.63 Million | 230.47 Thousand | 2.17 Million | -2.85 Million | 631.54 Thousand |
Depreciation & Amortization | 1.06 Million | 228 Thousand | 245.89 Thousand | 298.35 Thousand | 269.1 Thousand | 259.66 Thousand |
Deferred income taxes | - | 892.55 Thousand | -5395.00 | 398.55 Thousand | -527.35 Thousand | 178.77 Thousand |
Stock-based compensation | 146.66 Thousand | 382 Thousand | 44 Thousand | 22.71 Thousand | 32.5 Thousand | 52.42 Thousand |
Change in working capital | -457.33 Thousand | 2.04 Million | -2.19 Million | -3.39 Million | 3.04 Million | -891.28 Thousand |
Other non-cash items | 8.32 Million | 762.85 Thousand | -336.17 Thousand | 675.18 Thousand | 479.69 Thousand | -43.67 Thousand |
Investing Cash Flow | -18.66 Thousand | -243.72 Thousand | -117.57 Thousand | -201.16 Thousand | -517.54 Thousand | -288.74 Thousand |
Investments in PPE | -90.66 Thousand | -243.72 Thousand | -117.57 Thousand | -201.16 Thousand | -517.54 Thousand | -288.74 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 72 Thousand | - | - | - | - | - |
Financing Cash Flow | 4.54 Million | 1.17 Million | 4.02 Million | 81.52 Thousand | 206.57 Thousand | -501.21 Thousand |
Debt repayment | -436 Thousand | -435.83 Thousand | -226.3 Thousand | -379.96 Thousand | -171.16 Thousand | -511.61 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -7.16 Million | - | - | - |
Common Stock Issuance | - | 3.39 Million | 9 Million | 26.4 Thousand | 10.2 Thousand | 10.4 Thousand |
Other Financing Activities | 4.98 Million | -1.77 Million | 2.41 Million | 435.09 Thousand | 367.54 Thousand | 10.4 Thousand |
Accounts receivables | -7.02 Million | 579.65 Thousand | -622.29 Thousand | -139.54 Thousand | -188.52 Thousand | 196.65 Thousand |
Accounts payables | - | -3.51 Million | 2.51 Million | -3.19 Million | 4.19 Million | -772.04 Thousand |
Inventory | 553.33 Thousand | 3.98 Million | -8.39 Million | 1.9 Million | -1.75 Million | 2.53 Million |
Other working capital | 6.01 Million | 987.42 Thousand | 4.31 Million | -1.97 Million | 794.39 Thousand | -2.85 Million |
Cash at beginning of period | 2.29 Million | 2.29 Million | 396.57 Thousand | 345.2 Thousand | 211.4 Thousand | 813.9 Thousand |
Cash at end of period | 2.89 Million | 2.89 Million | 2.29 Million | 396.57 Thousand | 345.2 Thousand | 211.4 Thousand |
Capital Expenditure | -90.66 Thousand | -243.72 Thousand | -117.57 Thousand | -201.16 Thousand | -517.54 Thousand | -288.74 Thousand |
Effect of forex changes on cash | -4.47 Million | - | - | - | - | - |
Net cash flow / Change in cash | 604 Thousand | 604.09 Thousand | 1.89 Million | 51.37 Thousand | 133.79 Thousand | -602.5 Thousand |
Free Cash Flow | 457.33 Thousand | -574 Thousand | -2.12 Million | -30.14 Thousand | -72.78 Thousand | -101.28 Thousand |
Breakdown | 2024 Q4 | 2024 Q3 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.36 Million | -4.03 Million | -8.53 Million | 97.53 Thousand | -2.45 Million | -2.98 Million |
Depreciation & Amortization | 136 Thousand | 129.46 Thousand | 1.06 Million | 484.08 Thousand | 183.45 Thousand | 54.79 Thousand |
Deferred income taxes | - | - | - | 0.70 | -2.38 Million | 1.39 Million |
Stock-based compensation | 19 Thousand | - | 146.66 Thousand | 35.85 Thousand | 63.4 Thousand | 74.17 Thousand |
Change in working capital | -1.1 Million | 5.24 Million | -457.33 Thousand | 724.94 Thousand | -468.93 Thousand | 3.2 Million |
Other non-cash items | 581 Thousand | -2.35 Million | 8.32 Million | 31.63 Thousand | 2.52 Million | 189.53 Thousand |
Investing Cash Flow | -42.5 Thousand | 118.00 | -18.66 Thousand | 28.38 Thousand | -42.5 Thousand | -94.75 Thousand |
Investments in PPE | -42.5 Thousand | -22.00 | -90.66 Thousand | -25.47 Thousand | -42.5 Thousand | -94.75 Thousand |
Acquisitions | - | 140.00 | - | 53.86 Thousand | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 72 Thousand | 53.86 Thousand | - | - |
Financing Cash Flow | -21 Thousand | 1.9 Million | 4.54 Million | -79.88 Thousand | 1.58 Million | -1.73 Million |
Debt repayment | -21 Thousand | -20.14 Thousand | -436 Thousand | -79.88 Thousand | -23.97 Thousand | -716.1 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 1.92 Million | - | 1.00 | 1.6 Million | 30.52 Thousand |
Other Financing Activities | -21 Thousand | 109.00 | 4.98 Million | -79.88 Thousand | 5891.00 | -1.05 Million |
Accounts receivables | 3.75 Million | 3.81 Million | -7.02 Million | -10.25 Million | 1.42 Million | 4.96 Million |
Accounts payables | -3.66 Million | -4.91 Million | - | 9.88 Million | 875.34 Thousand | -252.35 Thousand |
Inventory | 379 Thousand | 3.95 Million | 553.33 Thousand | -2.43 Million | -1.1 Million | 1.2 Million |
Other working capital | -1.57 Million | 2.39 Million | 6.01 Million | 3.53 Million | -1.66 Million | -2.71 Million |
Cash at beginning of period | 6.7 Million | 3.21 Million | 2.29 Million | 1.89 Million | 2.89 Million | 2.79 Million |
Cash at end of period | 4.12 Million | 6.7 Million | 2.89 Million | 3.21 Million | 1.89 Million | 2.89 Million |
Capital Expenditure | -42.5 Thousand | -22.00 | -90.66 Thousand | -25.47 Thousand | -42.5 Thousand | -94.75 Thousand |
Effect of forex changes on cash | - | 426.00 | -4.47 Million | -1.32 Million | - | - |
Net cash flow / Change in cash | -2.57 Million | 3.49 Million | 604 Thousand | 1.32 Million | -1 Million | 99.4 Thousand |
Free Cash Flow | -2.59 Million | 1.58 Million | 457.33 Thousand | 1.34 Million | -2.59 Million | 1.83 Million |
4997
600236
KPIG
CLPR
5673
ZENLABS